Artículos del autor

solaci

Chronic Ischemic cardiopathy

Balancing Bleeding Risk vs. Thrombotic Risk to Define Dual Antiplatelet Therapy Duration

Patients who undergo complex angioplasty are at higher ischemic risk, but only benefit from extended dual antiplatelet...
solaci -
Aorta

Surveillance after EVAR: When and How Long

It has been suggested that surveillance after endovascular abdominal aorta aneurysm repair (EVAR) should be for life,...
solaci -
Coronary disease

In-Hospital Costs and Costs of Complications of Chronic Total Occlusions

Is a chronic total occlusion worth rechanneling? This question can often be found in different studies, all...
solaci -
Structural heart disease

We Must Still Fear the “Big Five Complications” After TAVR

Surgical risk scores cannot be used for transcatheter aortic valve replacement (TAVR) and they usually overestimate procedural...
solaci -
Coronary disease

DES and DCB with Similar Results in Femoropopliteal Artery Disease

Courtesy of Dr. Carlos Fava. Nowadays, peripheral interventions are on the rise and the technological development of stents and...
solaci -
Structural heart disease

Transcaval Access Is Safe in TAVR

Courtesy of Dr. Carlos Fava. One of the limitations to percutaneous interventions is poor or impossible femoral access....
solaci -
Carotid

Paladin: New Carotid Protection System with Good Results

Courtesy of Dr. Carlos Fava. Carotid artery stenting (CAS) with a cerebral protection system has emerged as an...
solaci -
Structural heart disease

After 100,000+ Patients, TAVR Becomes the New Standard of Care

Eighty years did the trick for one the countries with more experience in transcatheter aortic valve replacement...
solaci -